Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-02-27
2007-02-27
Weber, Jon (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S350000
Reexamination Certificate
active
10804937
ABSTRACT:
Polypeptides or proteins comprising tissue inhibitor of mettaloproteinases-3 (TIMP3) or variants of TIMP3 can be used to substantially inhibit vascular endothelial growth factor (VEGF) binding to VEGF recptor-2 (VEGFR2/KDR/Flk-1)) without substantially inhibiting VEGF binding to VEGF receptor 1 (VEGFR1/Flt-1).
REFERENCES:
patent: WO 95/05478 (1995-02-01), None
patent: WO 95/09918 (1995-04-01), None
Qi et al., ARVO Annual Meeting Abstract Search and Program Planner, Abstract No. 2753, May 5-10, 2002.
Database NCBI Conserved Domain Search for Human TIMP3, printed on Oct. 28, 2005.
Cleveland Clinic Foundation
Kosson Rosanne
Tarolli, Sundheim Covell & Tummino LLP
Weber Jon
LandOfFree
TIMP3 as VEGF inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TIMP3 as VEGF inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TIMP3 as VEGF inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3873284